IM Journal Club
Claim This Podcastby IM Journal Club
Podcast Overview
<p>Journal-Clubbing Our Way Through Internal Medicine</p><br><p>Do you also find it hard to follow the medical literature?</p><p>Newsletters with tables of contents are hard to get through after having written all your notes and maybe having done a chart dissection.</p><br><p>Welcome to IM Journal Club!</p><p>Our mission: to guide you through some of the most interesting internal medicine studies published in the last few weeks and months that you WOULD have liked to or SHOULD have heard about</p><br><p>Target groups: physicians and other clinicians in general internal or family medicine – hospital medicine and primary care – or in an internal medicine subspecialty; biostatisticians, epidemiologists, or data scientists; journal club enthusiasts!</p><br><p>Hidden agenda: to shed some lights on the studies’ methods AND on the context (what was known before, how do the new results change things – so what does this all mean?). We will give you episodes with primers on particularly difficult methods.</p><br><p>We will come out with a new episode every one to two weeks - we'll upload early on Fridays - so you can listen on your commute or on the weekend.</p><br><p>Please subscribe in your favorite podcast app or to our YouTube channel .</p><br><p>Please let us know what we can do better, or what new study we could cover: You can leave a review in your podcasting app, a comment on YouTube, or drop us a line at hello@imjournalclub.com</p><br><p>We are also on social; our email newsletter will be on Twitter: https://twitter.com/IMJournalClub</p><br><p>---</p><p>Show Credits</p><p>Host: Ben Geisler</p><p>Video editor: Fernando Tábora</p><p>Methods consultant: Professor Ulrich Mansmann</p><p>Advisory group (current): Bijay Acharya, Chang-Berm Kang, Jeffrey L. Greenwald, Jonathan W. Heflin, Kathy May Tran, Marcel Müller, Rahul Ganatra, and Warren Chuang</p><p>Supported by LMU Munich’s Institute for Epidemiology, Biometry, and Medical Information Processing</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
10/27/2022
1 verified contact email on file for IM Journal Club
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
December 23, 2022
Doxycycline for Community Acquired Pneumonia w/ Dr. Brad Spellberg
<p>Doxycycline is an old tetracycline-like antibiotic with a comparatively good side-effect profile, but it doesn’t get much love in the guidelines for community-acquired pneumonia as the evidence level was deemed to be low. A recent issue of Clinical Infectious Diseases contained a systematic review with a meta-analysis.</p><p> </p><p><a href="https://twitter.com/BradSpellberg" rel="noopener noreferrer" target="_blank">Dr. Brad Spellberg</a> is the chief medical office at the Los Angeles County-University of Southern California Medical Center. Dr. Spellberg is also a professor of clinical medicine and the associate dean for clinical affairs at the USC’s Keck School of Medicine.</p><p> </p><p>I talk with him about why doxy might be a good CAP drug (and when it is not a good choice), guidelines and the process of creating guidelines, and resistance patterns, MICs, and clinical significance.</p><p> </p><p>References:</p><p>-Shorter Is Better: <a href="https://www.bradspellberg.com/shorter-is-better" rel="noopener noreferrer" target="_blank">https://www.bradspellberg.com/shorter-is-better</a> </p><p>-Oral Is the New IV: <a href="https://www.bradspellberg.com/oral-antibiotics" rel="noopener noreferrer" target="_blank">https://www.bradspellberg.com/oral-antibiotics</a> </p><p>-WikiGuidelines: <a href="https://www.wikiguidelines.com/" rel="noopener noreferrer" target="_blank">https://www.wikiguidelines.com/</a> </p><p>-SH Choi et al.: Clin Infect Dis. 2022 Jul 29;ciac615. <a href="https://pubmed.ncbi.nlm.nih.gov/35903011/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/35903011/</a></p><p>-NICE: Pneumonia (community-acquired): antimicrobial prescribing. Published: 16 September 2019. <a href="https://www.nice.org.uk/guidance/ng138" rel="noopener noreferrer" target="_blank">https://www.nice.org.uk/guidance/ng138</a></p><p>-JP Metlay et al. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST. <a href="https://pubmed.ncbi.nlm.nih.gov/31573350/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/31573350/</a></p><p> </p><p>YouTube channel: <a href="https://www.youtube.com/@IMJournalClub" rel="noopener noreferrer" target="_blank">https://www.youtube.com/@IMJournalClub</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
December 16, 2022
Colonoscopy For Colorectal Cancer Screening: NordICC w/ Dr. Michael Bretthauer
<p>The NordICC Study is the first randomized controlled trial to test colonoscopy as a screening modality for colorectal cancer. The effect of colonoscopy was lower than previously thought. </p><p>We talk with the P.I., Dr. Michael Bretthauer, what to make of the study and whether (and in which areas) we should remain doubtful. Dr. Bretthauer is a professor of medicine at the University of Oslo.</p><p> </p><p>References:</p><ul><li>M Bretthauer et al. N Engl J Med. 2022 Oct 27;387(17):1547-1556. <a href="https://pubmed.ncbi.nlm.nih.gov/36214590/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/36214590/</a></li><li>RL Siegel et al. CA Cancer J Clin. 2022;72:7-33. <a href="https://pubmed.ncbi.nlm.nih.gov/35020204/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/35020204/</a></li><li>Ø Holme et al. Ann Intern Med. 2018;168:775-82. <a href="https://pubmed.ncbi.nlm.nih.gov/29710125/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/29710125/</a></li><li>Global Cancer Observatory, <a href="https://gco.iarc.fr/" rel="noopener noreferrer" target="_blank">https://gco.iarc.fr/</a></li><li>M Bretthauer et al. Ann Int Med. 2017;166:139-40. <a href="https://pubmed.ncbi.nlm.nih.gov/27820949/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/27820949/</a></li><li>USPSTF: JAMA. 2021;325(19):1965-77 <a href="https://jamanetwork.com/journals/jama/fullarticle/2779985" rel="noopener noreferrer" target="_blank">https://jamanetwork.com/journals/jama/fullarticle/2779985</a></li><li>E Quintero et al. N Engl J Med. 2012;366:697-706 <a href="https://pubmed.ncbi.nlm.nih.gov/22356323/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/22356323/</a></li><li>AB Knudsen et al. JAMA. 2021;325(19):1998-2011 <a href="https://pubmed.ncbi.nlm.nih.gov/34003219/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/34003219/</a></li><li>Ex. calculator: <a href="https://ccrisktool.cancer.gov/calculator.html" rel="noopener noreferrer" target="_blank">https://ccrisktool.cancer.gov/calculator.html</a></li><li>LM Helsingen et al. BMJ. 2019367:l5515. <a href="https://pubmed.ncbi.nlm.nih.gov/31578196/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/31578196/</a></li></ul><p> </p><p>YouTube: <a href="https://youtu.be/mTxKbbcx9BY" rel="noopener noreferrer" target="_blank">https://youtu.be/mTxKbbcx9BY</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
December 2, 2022
Some ideas for the next episodes
<p>Here's our ideas, please cast your vote: <a href="https://www.youtube.com/@IMJournalClub/community" rel="noopener noreferrer" target="_blank">https://www.youtube.com/@IMJournalClub/community</a> </p><br><p>While you're on the channel page, please also subscribe: <a href="https://www.youtube.com/@IMJournalClub?sub_confirmation=1" rel="noopener noreferrer" target="_blank">https://www.youtube.com/@IMJournalClub?sub_confirmation=1</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
15 total episodes available
Deep-dive analytics for IM Journal Club
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is IM Journal Club?
<p>Journal-Clubbing Our Way Through Internal Medicine</p><br><p>Do you also find it hard to follow the medical literature?</p><p>Newsletters with tables of contents are hard to get through after having written all your notes and maybe having done a chart dissection.</p><br><p>Welcome to IM Journal Club!</p><p>Our mission: to guide you through some of the most interesting internal medicine studies published in the last few weeks and months that you WOULD have liked to or SHOULD have heard about</p><br><p>Target groups: physicians and other clinicians in general internal or family medicine – hospital medicine and primary care – or in an internal medicine subspecialty; biostatisticians, epidemiologists, or data scientists; journal club enthusiasts!</p><br><p>Hidden agenda: to shed some lights on the studies’ methods AND on the context (what was known before, how do the new results change things – so what does this all mean?). We will give you episodes with primers on particularly difficult methods.</p><br><p>We will come out with a new episode every one to two weeks - we'll upload early on Fridays - so you can listen on your commute or on the weekend.</p><br><p>Please subscribe in your favorite podcast app or to our YouTube channel .</p><br><p>Please let us know what we can do better, or what new study we could cover: You can leave a review in your podcasting app, a comment on YouTube, or drop us a line at hello@imjournalclub.com</p><br><p>We are also on social; our email newsletter will be on Twitter: https://twitter.com/IMJournalClub</p><br><p>---</p><p>Show Credits</p><p>Host: Ben Geisler</p><p>Video editor: Fernando Tábora</p><p>Methods consultant: Professor Ulrich Mansmann</p><p>Advisory group (current): Bijay Acharya, Chang-Berm Kang, Jeffrey L. Greenwald, Jonathan W. Heflin, Kathy May Tran, Marcel Müller, Rahul Ganatra, and Warren Chuang</p><p>Supported by LMU Munich’s Institute for Epidemiology, Biometry, and Medical Information Processing</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.